Literature DB >> 16741495

Achievements in public health. Reduction in perinatal transmission of HIV infection--United States, 1985-2005.

.   

Abstract

During 2005, an estimated 92% of acquired immunodeficiency syndrome (AIDS) cases reported among children aged <13 years in the United States were attributed to mother-to-child transmission of human immunodeficiency virus (HIV) (CDC, unpublished data, 2006). Transmission can occur during pregnancy, labor, delivery, or breastfeeding. Estimates of the number of perinatal HIV infections peaked in 1991 at 1,650 and declined to an estimated range of 144-236 in 2002 (CDC, unpublished data, 2006). This reduction is attributed to routine HIV screening of pregnant women, use of antiretroviral (ARV) drugs for treatment and prophylaxis, avoidance of breastfeeding, and use of elective cesarean delivery when appropriate. With these interventions, rates of HIV transmission during pregnancy, labor, or delivery from mothers infected with HIV have been reduced to less than 2%, compared with transmission rates of 25%-30% with no interventions.

Entities:  

Mesh:

Year:  2006        PMID: 16741495

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  83 in total

1.  Woman with congenital HIV infection and medication-induced Fanconi syndrome.

Authors:  Christian Mabry; Myra A Kleinpeter; D Luke Glancy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

2.  Rapid polymerase chain reaction assay to detect herpes simplex virus in the genital tract of women in labor.

Authors:  Carolyn Gardella; Meei-Li Huang; Anna Wald; Amalia Magaret; Stacy Selke; Rhoda Morrow; Lawrence Corey
Journal:  Obstet Gynecol       Date:  2010-06       Impact factor: 7.661

3.  Women's health: 30 years of progress in the U.S. Department of Health and Human Services.

Authors:  Caira M Woods; Bethany Applebaum; Yvonne Green; Deborah L Kallgren; Evelyn Kappeler
Journal:  Public Health Rep       Date:  2015 Mar-Apr       Impact factor: 2.792

4.  Missed Opportunities for Preventing Perinatal Transmission of Human Immunodeficiency Virus, Florida, 2007-2014.

Authors:  Mary Jo Trepka; Soumyadeep Mukherjee; Consuelo Beck-Sagué; Lorene M Maddox; Kristopher P Fennie; Diana M Sheehan; Maithri Prabhakar; Dan Thompson; Spencer Lieb
Journal:  South Med J       Date:  2017-02       Impact factor: 0.954

Review 5.  The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

Authors:  Myron S Cohen; Nick Hellmann; Jay A Levy; Kevin DeCock; Joep Lange
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  Comprehensive Approaches to the Diagnosis and Treatment of HIV Infection in the Community: Can "Seek and Treat" Really Deliver?

Authors:  Brian Conway; Harout Tossonian
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

7.  Progress in Women's Health: 1985-2015.

Authors:  Nancy C Lee
Journal:  Public Health Rep       Date:  2015 Mar-Apr       Impact factor: 2.792

8.  Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.

Authors:  E S Machado; C B Hofer; T T Costa; S A Nogueira; R H Oliveira; T F Abreu; L A Evangelista; I F A Farias; R T C Mercadante; M F L Garcia; R C Neves; V M Costa; J S Lambert
Journal:  Sex Transm Infect       Date:  2008-11-05       Impact factor: 3.519

9.  Highly active antiretroviral treatment for the prevention of HIV transmission.

Authors:  Reuben Granich; Siobhan Crowley; Marco Vitoria; Ying-Ru Lo; Yves Souteyrand; Christopher Dye; Charlie Gilks; Teguest Guerma; Kevin M De Cock; Brian Williams
Journal:  J Int AIDS Soc       Date:  2010-01-12       Impact factor: 5.396

10.  Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.

Authors:  Vlada V Melekhin; Bryan E Shepherd; Samuel E Stinnette; Peter F Rebeiro; Gema Barkanic; Stephen P Raffanti; Timothy R Sterling
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.